Galderma has launched Alastin, its regenerative skincare line, across Japan and key Asia-Pacific markets. Alastin—a peptide-based skincare system designed to support skin recovery post-procedure—represents Galderma's push beyond injectables into the higher-margin, recurring-revenue skincare category.
Devices & Tech
Galderma Rolls Out Alastin Regenerative Skincare Across JPAC Region
Swiss company expands its post-procedure and preventive skincare line into Japan and key Asia-Pacific markets, broadening the injectables-adjacent revenue stream.
Free alerts
Free: recall & rule-change alerts for your practice.
Get the recalls and state-law changes that hit your treatment room, in your inbox — free. Unsubscribe in one click.
Free · weekly · unsubscribe anytime. Privacy.
Alastin's expansion into JPAC signals Galderma's strategy to build skincare revenue alongside injectables—higher margins, recurring purchases.
Alastin products are typically recommended as part of a comprehensive treatment plan following toxin, filler, or laser procedures. The JPAC rollout is strategic because Japan and Australia are high-income markets with strong aesthetic procedure adoption and willingness to invest in ancillary skincare. For practices, Alastin represents a bundling opportunity: recommending a post-procedure skincare regimen increases patient lifetime value and creates a touchpoint for repeat sales. Galderma's regional expansion suggests confidence in Alastin's clinical profile and reimbursement/direct-pay economics. Practices already using Galderma injectables may find Alastin a natural add-on to their product mix.
Source: original report ↗
Frequently asked questions
What is Alastin skincare and how does it work?
Alastin is a peptide-based regenerative skincare line designed to support skin recovery after aesthetic procedures like injectables, fillers, and laser treatments. The system works by promoting the skin's natural healing process and is typically recommended as part of a comprehensive post-procedure treatment plan.
Why is Galderma expanding Alastin to Japan and Asia-Pacific markets?
Japan and Australia are high-income markets with strong aesthetic procedure adoption and proven willingness to invest in ancillary skincare products. The expansion reflects Galderma's confidence in Alastin's clinical profile and the direct-pay economics in these regions.
How can medspa practices use Alastin to increase patient lifetime value?
Practices can bundle Alastin as a post-procedure skincare regimen recommendation, creating recurring revenue and repeat sales touchpoints. This bundling strategy increases patient lifetime value by extending the treatment relationship beyond the initial procedure.
Is Alastin a good add-on product if we already use Galderma injectables?
Yes—Alastin is a natural complement to Galderma injectables because it's designed specifically to optimize recovery after toxin and filler procedures. Practices already using Galderma products have an established relationship and can easily integrate Alastin into their existing product mix.
What type of revenue does Alastin represent for aesthetic practices?
Alastin represents higher-margin, recurring-revenue skincare sales compared to one-time procedure fees. Post-procedure skincare creates a recurring revenue stream as patients repurchase products for maintenance and ongoing skin health.
Stay three moves ahead of every practice in your market.
Knowing it happened is table stakes. Inside MedSpa Pro hands you the play — what each move means for your margins, your license, and your patients, and exactly what to do about it — in a two-minute brief, twice a week. The owners who read it never get blindsided.
Get the edge · $20/moJoin the owners who run ahead of the industry. Cancel anytime, one click.